“Incompetence, racism and prejudice delayed my diagnosis”
Women and Parkinson's
Author: Manon DayPublished: 23 January 2020
Prep: Cook: Serves:
It took a decade for Manon Day to be diagnosed with
Parkinson’s – with clinicians treating her as though she was a drug addict,
causing her to feel “mistreated” and “powerless”. She explains the role being a
young black woman played in her delayed diagnosis – and why “we need more
awareness to break the myths and stereotypes” around who the condition affects
My Parkinson’s symptoms started at the age of 17, but it
wasn’t until 10 years later that I was diagnosed with the condition, aged 27.
Over the years, I was living with uncertainty and was
worried about my physical state. At first, I struggled with low blood pressure
and I was fainting several times a week. Now, my symptoms include stiffness,
difficulty moving, speech problems, bladder dysfunction, fatigue and more.
When I was officially diagnosed with Parkinson’s in 2011,
I was overwhelmed and in shock – it had taken a decade to get the right
diagnosis. I knew for sure that Parkinson’s was going to change everything.
Women are less likely to be diagnosed with Parkinson’s
compared to men. Being a young black woman played a huge role in my delayed
diagnosis. The neurologists I initially consulted stigmatised me. They didn’t
believe me when I explained my symptoms: they thought I was a drug addict. I
was mistreated and my experience was horrible. It reached the point where I
became very ill and could not walk because my body was so stiff. Racism was the
cause of my delayed diagnosis and I felt powerless.
Due to incompetence and prejudice, I did not receive the
medical care that I so desperately needed. Every time the paramedics rushed me
to the hospital emergency room, the neurologists sent me back home right away.
Consequently, I felt distressed and abandoned by the healthcare system.
I changed hospitals and thankfully, as of now, I receive the best medical care and treatment at the Montreal Neurological Institute and Hospital. I have had an excellent response to levodopa and through medication, diet and exercise, I’m managing my Parkinson’s.
“It’s a devastating diagnosis to receive in the
prime of your life”
When I told my family about my diagnosis, they were stunned, as we thought that the condition usually afflicts the elderly. We started researching it intensely. Although my movement disorder specialist gave me lots of information about Parkinson’s, I had no knowledge about how the condition affects women in general – for example how I experience more symptoms of rigidity and slowness during my periods.
There were several challenges related to my young onset
diagnosis: I couldn’t pursue my studies in the field of translation, and I
chose not to conceive children because pregnancy is a risk to my health. In
addition to my Parkinson’s, I live with a second rare disease called acromegaly,
which I was diagnosed with in 2014. It’s a hormonal disorder that affects
approximately 2,000 people in Canada. It’s a damaging and incurable disease and,
as far as I know, I am the only person in the world living with both young
onset Parkinson’s and acromegaly.
Parkinson’s has also had negative effects on my hobbies and social life – it’s a devastating diagnosis to receive in the prime of your life when you are full of plans for the future.
“Parkinson’s doesn’t only affect old Caucasian
Generally speaking, women and people from minority backgrounds are underrepresented in the Parkinson’s research community. I am registered in a clinical Parkinson’s trial database called the Quebec Parkinson’s Network because I want to be involved and share my experience to advance knowledge in the scientific community. I think playing a small role can have a positive impact in the development of future therapies.
I’ve never met other black men or women with Parkinson’s in Montreal – and while I’m in contact with a few people online, I don’t know the details of their personal stories. It’s a sad reality that minorities face several challenges to get diagnosed correctly with Parkinson’s. That’s why three years ago I created a Facebook group called Everything about Parkinson’s Disease to connect with fellow patients, young or old – and of different races. It now has over 9,000 members worldwide. Running the group gives me a sense of purpose and I’m very happy to make a difference in people’s lives.
We need more awareness to break the myths and stereotypes around the condition. Parkinson’s doesn’t only affect old Caucasian men. It can impact anyone, regardless of age or ethnicity.
Need to know: Manon Day is 35 years old and lives in Montreal, Canada. She was diagnosed with Parkinson’s in 2011, age 27, and subsequently quit her studies in translation. She is now a Parkinson’s campaigner and runs a Facebook group called Everything about Parkinson’s Disease to raise awareness of the condition and how it can affect people of all backgrounds.
The facts: who does Parkinson’s affect?
Parkinson’s affects people of all racial and ethnic backgrounds and cultures
Around 10 million people across the globe live with the condition – and by 2040, it is estimated that there will be 13 million people with Parkinson’s
Our ‘In My Country’ series features interviewees from organisations around the world to spotlight the differing experiences of and attitudes towards people with Parkinson’s globally
Women and Parkinson’s: Our campaign
It is estimated that three million women worldwide are living with Parkinson’s – yet their specific needs and experiences are often ignored, leading to disparities in diagnosis, treatment and medication. Each week, we’ll be sharing the little-heard stories of women with the condition to find out how their lives are being affected by a shocking data gap when it comes to women and Parkinson’s. This is just the start.
We want to raise awareness of women’s experience of the condition within the medical profession, so that women’s symptoms are taken seriously.
We think more research is needed into the impact of Parkinson’s on women, so that they can benefit from tailored medication and treatment.
We want to explore ways to offer better support for those women managing the condition alongside caring responsibilities.
Join us – #WomenAndParkinsons.
For more information on women and Parkinson’s please visit the EPDA website.
If you have a story to tell about being a woman with Parkinson’s – or some information about the impact of the condition on women for us to share with the global Parkinson’s community – please get in touch.
5 free books to help explain Parkinson’s to children and teens
How to talk to young children about Parkinson’s disease
12 hours ago
Does deep brain stimulation for Parkinson’s increase the risk of dementia?
Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”
Researchers “stunned” by study that raises hopes for Parkinson’s treatment
A new study reprogramming cells to replace reduced dopamine neurons in the brain could be used to reverse symptoms of Parkinson’s and other neurological conditions. As part of the study – conducted by the University of California San Diego (UCSD) – researchers found a way to convert star-shaped brain cells called astrocytes into cells producing dopamine. The team used the method to treat mouse models of Parkinson’s, administering the treatment into the areas of the brain that typically lose dopamine producing neurons. This restored reduced dopamine production to normal levels and reversed the symptoms of Parkinson’s. The researchers will continue to optimise the therapy in other mouse models of Parkinson’s before testing it on people with the condition. William Mobley, a neurosciences professor at UCSD, said: “I was stunned at what I saw. This whole new strategy for treating neurodegeneration gives hope that it may be possible to help even…
Could a magnetically powered implant treat Parkinson’s tremors?
A tiny surgical implant about the size of a grain of rice that can be implanted with minimally invasive surgery may be used to treat tremors in people with Parkinson’s. Developed by a team of researchers at Rice University, US, the implant uses a thin film of magnetoelectric material to convert acoustic waves from the brain’s magnetic field into electrical voltage. The device produces the same high-frequency signals as clinically approved implants used to treat Parkinson’s, epilepsy and other conditions – and eliminates the need for battery or wired power supply. In an initial study, the researchers showed that the implants worked in rodents. Professor Jacob Robinson, corresponding author of the study, said: “Our results suggest that using magnetoelectric materials for wireless power delivery is more than a novel idea. These materials are excellent candidates for clinical-grade, wireless bioelectronics.”